GEA Pharma Solids Insight stories
Insight stories
Continuous Innovation: How GEA is Leading the Future of Pharmaceutical Manufacturing
From the first ConsiGma® line in 2004 to the launch of CDC Flex today, GEA has been at the forefront of pharmaceutical innovation.
Continuous innovation is our commitment — to our customers, to the industry, and to a better world.
How continuous manufacturing is redefining the pharmaceutical supply chain
Continuous pharmaceutical manufacturing is no longer a niche trend. It’s already happening. Although implementation and knowledge transfer can be time consuming, early adopters are embarking on a new trajectory of business excellence, benefiting from numerous competitive advantages and staying ahead of the market.
Insulina w wojnie z cukrzycą
Według szacunków Światowej Federacji Cukrzycy (International Diabetes Federation, IDF) w 2030 roku liczba diabetyków przekroczy 550 milionów — czyli 10% wszystkich osób dorosłych na planecie. Światowa Organizacja Zdrowia przewiduje natomiast, że liczba zgonów wiązanych z cukrzycą wzrośnie o dwie trzecie.
The unsung heroes of global health and well-being
When we consider the concept of health, we generally think about being free from injury or illness. We might look at a person’s mental or physical condition, or delve more deeply into nutrition, exercise, sleep and the environment we live in. In recent times, vaccines and medicines have taken center stage as the world battles the ongoing pandemic. Yet, often behind the scenes and anonymous, a vast array of technologies and innovations are working hard, every day, to ensure that the food, drugs, water and energy that we use to stay well are safe, reliable and sustainable. At the heart of many of those processes – and supporting healthy living – is GEA equipment.
